HHS - 21 CFR PART 1107
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
active, Most Current
| Organization: | HHS |
| Publication Date: | 1 April 2021 |
| Status: | active |
| Page Count: | 3 |
Document History
April 1, 2023
EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS
(a) Subparts B through E of this part apply to a substantial equivalence report (or an SE Report) for a new tobacco product, other than ‘‘premium’’ cigars as defined in § 1107.12, that has:
(1)...
April 1, 2022
EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
21 CFR PART 1107
April 1, 2021
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2020
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2019
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2018
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2017
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2016
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
General requirements. Under section 905(j)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 387e(j)(3)), FDA may exempt from the requirements relating to the demonstration that a tobacco...
April 1, 2015
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2014
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.